Cargando…
Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin
BACKGROUND: Platinum-containing chemotherapy produces specific DNA damage and is used to treat several human solid tumors. Tumors initially sensitive to platinum-based drugs frequently become resistant. Inhibition of DNA repair is a potential strategy to enhance cisplatin effectiveness. After cispla...
Autores principales: | Sand-Dejmek, Janna, Adelmant, Guillaume, Sobhian, Bijan, Calkins, Anne S, Marto, Jarrod, Iglehart, Dirk J, Lazaro, Jean-Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135565/ https://www.ncbi.nlm.nih.gov/pubmed/21679440 http://dx.doi.org/10.1186/1476-4598-10-74 |
Ejemplares similares
-
DNA damage-induced inhibition of rRNA synthesis by DNA-PK and PARP-1
por: Calkins, Anne S., et al.
Publicado: (2013) -
The Chromatin Remodeling Factor CHD5 Is a Transcriptional Repressor of WEE1
por: Quan, Jinhua, et al.
Publicado: (2014) -
An autonomous chromatin/DNA-PK mechanism for localized DNA damage signaling in mammalian cells
por: Muñoz, Denise P., et al.
Publicado: (2013) -
DNA-PK(cs) promotes chromatin decondensation to facilitate initiation of the DNA damage response
por: Lu, Huiming, et al.
Publicado: (2019) -
Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)